Literature DB >> 2296620

Behavioral performance effects of nifedipine in normotensive and renovascular hypertensive baboons.

J S Turkkan1, R D Hienz.   

Abstract

Behavioral performances of normotensive and hypertensive adult male baboons were tested before, during, and following chronic oral dosing with nifedipine. Performances during a five-color simultaneous match-to-sample task were measured during three dosing schedules (0.20, 0.68, and 1.14 mg/kg/day) and vehicle. Each dose was administered for 21 consecutive days preceded and followed by 14-day baseline and recovery periods, respectively. Choice reaction times increased by 191 ms over baseline at the 0.68 mg/kg dose. Choice reaction times above the 95th percentile (i.e., the slowest reaction times) were the most slowed by nifedipine. Accuracy of color matching was decreased at 0.20 and 0.68 mg/kg by an average range of 2-4%. The yellow and white stimuli were the most difficult to discriminate correctly, and were also the most impaired by nifedipine. Nifedipine's behavioral effects were not modulated by blood pressure changes because daily changes in choice reaction time and systolic blood pressure were not correlated, and hypertensive status did not determine the behavioral effects. Potential sources of nifedipine's behavioral performance effects are discussed, with blood pressure changes excluded as a probable mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296620     DOI: 10.1007/bf02245802

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Effect of calcium antagonist, nifedipine, on blood pressure of various hypertensive rats.

Authors:  J Iriuchijima
Journal:  Hiroshima J Med Sci       Date:  1980-03

2.  Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon.

Authors:  H C McGill; K D Carey; C A McMahan; Y N Marinez; T E Cooper; G E Mott; C J Schwartz
Journal:  Arteriosclerosis       Date:  1985 Sep-Oct

3.  Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action.

Authors:  E Mogilnicka; A Czyrak; J Maj
Journal:  Eur J Pharmacol       Date:  1987-06-26       Impact factor: 4.432

4.  Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.

Authors:  H Ishii; K Itoh; T Nose
Journal:  Eur J Pharmacol       Date:  1980-05-30       Impact factor: 4.432

5.  Nifedipine delays the acquisition of tolerance to ethanol.

Authors:  P H Wu; T Pham; C A Naranjo
Journal:  Eur J Pharmacol       Date:  1987-07-09       Impact factor: 4.432

6.  Effects of calcium antagonists on phencyclidine behaviors.

Authors:  G T Bolger; M F Rafferty; J N Crawley; S M Paul; P Skolnick
Journal:  Pharmacol Biochem Behav       Date:  1986-07       Impact factor: 3.533

7.  Pure tone thresholds in the yellow baboon (Papio cynocephalus).

Authors:  R D Hienz; J S Turkkan; A H Harris
Journal:  Hear Res       Date:  1982-09       Impact factor: 3.208

8.  Nifedipine in the treatment of hypertension in the elderly.

Authors:  J Stessman; B Leibel; Y Yagil; R Eliakim; D Ben-Ishay
Journal:  J Clin Pharmacol       Date:  1985-04       Impact factor: 3.126

9.  Barbiturates and nifedipine have different and selective effects on calcium currents of mouse DRG neurons in culture: a possible basis for differing clinical actions. The 1987 S. Weir Mitchell award.

Authors:  R A Gross; R L Macdonald
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

10.  Operant methodology in the study of learning.

Authors:  D M Thompson; J M Moerschbaecher
Journal:  Environ Health Perspect       Date:  1978-10       Impact factor: 9.031

View more
  2 in total

1.  Behavioral performance effects of verapamil in normotensive and renovascular hypertensive baboons.

Authors:  J S Turkkan; R D Hienz
Journal:  Integr Physiol Behav Sci       Date:  1992 Apr-Jun

2.  Central effects of the calcium antagonist, nifedipine.

Authors:  D G McDevitt; D Currie; A N Nicholson; N A Wright; M B Zetlein
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.